PlainRecalls
FDA Drug Moderate Class II Ongoing

Timolol Maleate Ophthalmic Solution USP, 0.5%, packaged in: a) 5mL bottle (NDC 64980-514-05), and b) 10mL bottle (NDC 64980-514-01), Rx only, Manufactured by: FDC Limited, Waluj, Aurangabad, India, Distributed by: Rising Pharmaceuticals Inc, New Jersey

Reported: August 28, 2024 Initiated: August 12, 2024 #D-0642-2024

Product Description

Timolol Maleate Ophthalmic Solution USP, 0.5%, packaged in: a) 5mL bottle (NDC 64980-514-05), and b) 10mL bottle (NDC 64980-514-01), Rx only, Manufactured by: FDC Limited, Waluj, Aurangabad, India, Distributed by: Rising Pharmaceuticals Inc, New Jersey

Reason for Recall

Defective Container: patients are unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.

Details

Recalling Firm
FDC Limited
Units Affected
176,784 bottles
Distribution
Nationwide U.S.A.
Location
Aurangabad, Maharashtra State

Frequently Asked Questions

What product was recalled?
Timolol Maleate Ophthalmic Solution USP, 0.5%, packaged in: a) 5mL bottle (NDC 64980-514-05), and b) 10mL bottle (NDC 64980-514-01), Rx only, Manufactured by: FDC Limited, Waluj, Aurangabad, India, Distributed by: Rising Pharmaceuticals Inc, New Jersey. Recalled by FDC Limited. Units affected: 176,784 bottles.
Why was this product recalled?
Defective Container: patients are unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 28, 2024. Severity: Moderate. Recall number: D-0642-2024.